CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

XERSXeris Biopharma Holdings, Inc.

NASDAQ · Pharmaceutical Preparations
Last close $9.56 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Preparations
Market cap$1.74B
RECENT INSIDER TRADES
  • 2026-10-02 · Pieper Steven (See Remarks) · SELL
  • 2026-10-02 · McCulloch Kevin (See Remarks) · SELL
  • 2026-10-02 · Hecht Beth (See Remarks) · SELL
  • 2026-09-29 · McCulloch Kevin (See Remarks) · SELL
  • 2026-09-01 · Hecht Beth (See Remarks) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders255
Shares held132,968,257
Value$976.10M
Percent of shares outstanding72.93%
As of quarter end2026-06-30
RECENT NEWS
  • Lundbeck approaches Xeris Biopharma over potential takeover, Bloomberg reports
  • Xeris Biopharma jumps on report of interest from H Lundbeck
  • Lundbeck Is Said to Express Interest in Buying Xeris Biopharma
  • Xeris Biopharma stock hits 52-week high at 10.08 USD
  • Xeris Biopharma Holdings, Inc. · 8-K (7.01,9.01)
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Xeris Biopharma Holdings, Inc. (XERS) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit